Clinical trials
Immunogenicity clinical trials
Below are recruiting immunogenicity clinical trials, each written for real people, not researchers. We’re tracking 149 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07384104Enrolling by invitationPhase 1
Comparing a new bone drug (SAL023) to Evenity in healthy volunteers
This trial tests a new medicine called SAL023 to see how it compares to an approved drug (Evenity) in healthy people. It looks at how the body processes the drug, safety, and immune response. You must be healthy, within a certain age and weight range, and not have any bone or heart problems.
Hefei, AnhuiAges 18–45 - NCT07330440Enrolling by invitationPhase 1
MRNA vaccine study for preventing genital herpes
This study tests a new mRNA vaccine designed to protect against herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. It is for healthy adults who have not had a genital herpes outbreak in the last 6 months.
BeijingAges 18–55 - NCT05983874Enrolling by invitationPhase 1
Booster HIV vaccine study for those who got the first shots
This study tests two booster doses of an HIV vaccine to see if they are safe and boost the immune system. It is for healthy adults who already received three earlier doses of a related vaccine.
AmsterdamAges 18–51 - NCT05015686Enrolling by invitationPhase 3
Live chickenpox vaccine safety study for healthy teens and adults
This trial tests how safe and how well a live, weakened chickenpox (varicella) vaccine works in healthy people age 13 and older. If you qualify, you may receive the study vaccine and be monitored for side effects and immune response.
Shangqiu, HenanAges 13 years+ - NCT03170141Enrolling by invitationPhase 1
T-cell therapy for recurrent brain tumor
This Phase 1 study tests modified immune T-cells to treat recurrent glioblastoma (a fast-growing brain tumor) that can be seen on scans. Because it’s early-stage, the goal is mainly safety, but you may be helping researchers understand if the treatment can shrink tumors.
Shenzhen, GuangdongAges 6–70
Hear when a new Immunogenicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for immunogenicity?
- Yes. Clin2 currently lists 149 recruiting immunogenicity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a immunogenicity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a immunogenicity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.